Clear Street’s Reviva Pharmaceuticals Warrants RVPHW Stock Holding History

Clear Street’s Portfolio RVPHW Stock Details RVPHW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-22	Closed	-$1	–	885
2025 Q2	$1	Buy	+22	New	+$1	﹤0.01%	680
2025 Q1	–	Sell	-100	Closed	-$16	–	603
2024 Q4	$16	Buy	+100	New	+$17	﹤0.01%	562

Other funds holding RVPHW

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Clear Street's RVPHW Position: Q3 2025 in Review

Clear Street sold out of Reviva Pharmaceuticals Warrants (RVPHW) in Q3 2025, closing a stake of 22 shares — an estimated $1 sold.

Clear Street first reported a position in RVPHW in Q4 2024 and held it in 2 quarters. The position peaked at $16 in Q4 2024. 2 funds tracked by Wall St. Rank hold RVPHW as of Q3 2025.

Clear Street reported no remaining Reviva Pharmaceuticals Warrants position as of Q3 2025 after selling out during the quarter.
Clear Street sold 22 Reviva Pharmaceuticals Warrants shares in Q3 2025, an estimated $1.
Clear Street first reported a position in Reviva Pharmaceuticals Warrants in Q4 2024 and held it in 2 quarters.
Clear Street's Reviva Pharmaceuticals Warrants position peaked at $16 in Q4 2024.
2 funds tracked by Wall St. Rank held Reviva Pharmaceuticals Warrants as of Q3 2025.

Based on Clear Street's 13F filing for Q3 2025, filed 14 Nov 2025.